The quiet MedTech pivot to Latin America

A recent industry analysis titled “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility” shows that the global medical-device industry is increasingly turning its attention to Latin America in 2025 as a market-entry and supply-chain diversification strategy. The report notes that in April 2025 the U.S. administration imposed sweeping tariffs affecting device imports from more than 180 countries.

Latin America emerges as an attractive alternative because of rising demand for medical technologies (due to aging populations and chronic-disease burdens), relatively lower tariff exposure compared to the U.S., and an expanding network of distributors and commercialization partners in LATAM. However, regulatory fragmentation, limited reimbursement infrastructure and diverse country-by-country requirements remain key obstacles.

Sources:

• “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility.”. Link